Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke (ESS)

This study has been completed.
Sponsor:
Collaborators:
Johnson & Johnson
Parexel
Information provided by:
Max-Planck-Institute of Experimental Medicine
ClinicalTrials.gov Identifier:
NCT00604630
First received: January 17, 2008
Last updated: October 21, 2008
Last verified: September 2008